Early low-dose aspirin after clot-busting for acute stroke
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether taking a low dose of aspirin soon after a stroke, when clot-busting medication has already been given, is safe and helps improve recovery. It may help prevent another stroke and is designed for people whose strokes are caused by blocked blood vessels in the brain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You received clot-busting treatment (called thrombolysis) within 3 hours of your stroke starting.
- Your stroke symptoms have lasted for more than 1 hour and a CT scan shows no bleeding in the brain.
- You do not have atrial fibrillation (a heart rhythm problem) or another known cause of stroke from the heart.
- You can swallow pills and are not currently on blood thinners (anticoagulants).
- You do not have a severe infection or a very severe stroke.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving an antiplatelet medicine (like aspirin) early—within 3 hours of a clot-busting drug—can help prevent another stroke without causing bleeding. It is for people who still have moderate to severe stroke symptoms after the clot-buster and do not have a large artery blockage.
This trial studies whether starting aspirin early is safe and helpful for people who, after clot-busting treatment for an ischemic stroke, develop a specific type of small brain bleeding called hemorrhagic infarction. You might benefit if your scan later shows this pattern of bleeding and you are not able to take blood-thinners or aspirin is safe for you.
This trial tests whether a combination of a clot-preventing drug (tirofiban) followed by two antiplatelet drugs (aspirin and clopidogrel) can improve recovery in people who have had a mild stroke. It aims to find a better way to prevent further strokes or worsening symptoms.
This study compares two ways to treat a minor stroke: taking two blood-thinning pills (aspirin and clopidogrel) versus receiving a clot-busting medicine (alteplase) through an IV. The goal is to see which approach works better and has fewer side effects.
This trial tests whether giving a clot-busting drug to people with mild stroke symptoms (but no limb weakness) can improve recovery. It aims to see if this treatment is safe and helpful for this specific group.
This trial tests whether giving a clot-dissolving medicine (alteplase or tenecteplase) is safe and effective for people who have had a stroke and are taking a blood thinner (DOAC) like apixaban or rivaroxaban. It aims to see if this treatment can still be given within a few hours of the stroke.
Hear when a new Cerebral Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.